Is Indian Pharma Growth Doomed?

Article by Christopher Ward from Pharmaceutical Executive

Read more

The global burden of NCDs

An overview of the worldwide economic and health impacts of NCDs

Read more

India's growing healthcare crisis

Challenges of equity, capacity and funding

Read more

CBO report: further restricting DTC advertising may be bad for public health

Guest blog by Susan Huggett, President of Torre Lazur McCann Canada

Read more

Highlighted Articles

: Christopher Ward
: June 12, 2013

Guest column - Is Indian Pharma’s spectacular growth Bonanza or Bubble?

From Apothecurry
... More »

: Articles, Generic medicines, India, innovation
: Christopher Ward
: June 4, 2013

Is Indian Pharma Growth Doomed?

Indian pharmaceutical companies’ profits have grown hugely in recent years, largely due to the sale of generics to the US and EU markets. But, with the next... More »

: Articles, Generic medicines, India, innovation
: Christopher Ward
: June 4, 2013

World Health Advocacy appoints Christopher Ward as Senior Partner

World Health Advocacy announces the appointment of Christopher Ward as Senior Partner, who returns to the company he founded in 2001.  In 2008, Ward joined... More »

: Articles
: Steven Lott
: April 5, 2013

World Health Day 2013

According to the World Health Organization, one in three adults worldwide has high blood pressure -- the focus of this year's World Health Day (April 7th).... More »

: Articles, Global, Global health, NCDs